×
About 12,890 results

ALLMedicine™ Aortic Stenosis Center

Research & Reviews  4,501 results

Rapid deployment technology versus conventional sutured bioprostheses in aortic valve r...
https://doi.org/10.1111/jocs.16223
Journal of Cardiac Surgery; Salmasi MY, Ramaraju S et. al.

Jan 15th, 2022 - Despite the benefits of rapid deployment aortic valve prostheses (RDAVR), conventional sutured valves (cAVR) are more commonly used in the treatment for aortic stenosis. Given the paucity of randomized studies, this study aimed to synthesize avail...

Economic Considerations in Access to Transcatheter Aortic Valve Replacement.
https://doi.org/10.1161/CIRCINTERVENTIONS.121.011489
Circulation. Cardiovascular Interventions; Reddy KP, Groeneveld PW et. al.

Jan 14th, 2022 - Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, with the number of procedures and sites offering the procedure steadily rising over the past decade in the United States. Despite this, growth into ...

The effect of the learning curve on paravalvular aortic regurgitation and mid-term mort...
https://doi.org/10.1111/echo.15289
Echocardiography (Mount Kisco, N.Y.); Istrate M, Dregoesc MI et. al.

Jan 14th, 2022 - Paravalvular aortic regurgitation is an important independent mortality predictor in transcatheter aortic valve implantation (TAVI). Our study evaluated the association between paravalvular aortic regurgitation and mid-term mortality in relation w...

Efficacy and Safety of Emergent Transcatheter Aortic Valve Implantation in Patients wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719985
Journal of Interventional Cardiology; Shao R, Li J et. al.

Jan 14th, 2022 - The aim of this systematic review and meta-analysis was to investigate the efficacy and safety of emergent transcatheter aortic valve implantation (TAVI) in patients with decompensated aortic stenosis (AS) by comparing the clinical outcomes with t...

Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis pati...
https://doi.org/10.1002/ccd.30066
Catheterization and Cardiovascular Interventions : Offici... Chiou A, Yap J et. al.

Jan 13th, 2022 - We describe the causes, timing and predictors of readmissions and analyze its impact on clinical outcomes in intermediate-to-high-risk patients with severe symptomatic aortic stenosis (AS) who underwent transcatheter aortic valve replacement (TAVR...

see more →

Guidelines  3 results

The Rationale for Performance of Coronary Angiography and Stenting Before Transcatheter...
https://doi.org/10.1016/j.jcin.2016.09.024
JACC. Cardiovascular Interventions; Ramee S, Anwaruddin S et. al.

Dec 10th, 2016 - Transcatheter aortic valve replacement (TAVR) is an effective, nonsurgical treatment option for patients with severe aortic stenosis. The optimal treatment strategy for treating concomitant coronary artery disease (CAD) has not been tested prospec...

Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR.
https://doi.org/10.1016/j.jcmg.2014.12.014
JACC. Cardiovascular Imaging; Hahn RT, Little SH et. al.

Mar 17th, 2015 - Recent multicenter trials have shown that transcatheter aortic valve replacement is an alternative to surgery in a high risk population of patients with severe, symptomatic aortic stenosis. Echocardiography and multislice computed tomographic imag...

Transcatheter aortic valve replacement program development: recommendations for best pr...
https://doi.org/10.1002/ccd.25529
Catheterization and Cardiovascular Interventions : Offici... Hawkey MC, Lauck SB et. al.

Apr 25th, 2014 - Transcatheter aortic valve replacement (TAVR) is an increasingly available therapy for the management of aortic stenosis in higher risk populations. Beyond addressing the procedural challenges, centers must attend to the unique requirements of dev...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  149 results

Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis
https://clinicaltrials.gov/ct2/show/NCT02436655

Jan 12th, 2022 - Aortic valve replacement (AVR) therapy is obvious choice in symptomatic severe aortic stenosis (AS) patients, because it improves symptoms, LV function and survival. Therefore, the accurate diagnosis of the disease, determination of its severity a...

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
https://clinicaltrials.gov/ct2/show/NCT04899180

Jan 11th, 2022 - Residents of Southeast Minnesota over 75 years of age with an inpatient or outpatient diagnosis of moderate or severe aortic stenosis will be consecutively identified using an automated bi-weekly review of the echo lab calendar (on Mondays and Fri...

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
https://clinicaltrials.gov/ct2/show/NCT03315832

Jan 10th, 2022 - Aortic stenosis (AS) is the most frequent valvular heart disease in Western countries, with increasing prevalence. Recent guidelines recommend aortic valve intervention (surgical aortic valve replacement [SAVR] or transcatheter aortic valve replac...

Williams Syndrome (WS) and Supravalvular Aortic Stenosis (SVAS) DNA and Tissue Bank
https://clinicaltrials.gov/ct2/show/NCT02706639

Jan 4th, 2022 - Our goal with the Williams syndrome (WS) and Supravalvular Aortic Stenosis (SVAS), deoxyribonucleic acid (DNA) and Tissue Bank is to collect enough samples from individuals with this rare condition to ask questions about the genes that cause the m...

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
https://clinicaltrials.gov/ct2/show/NCT03557242

Jan 4th, 2022 - This study aims to examine the optimal anticoagulation/antiplatelet regimen in low risk patients undergoing TAVR. The prospective randomized controlled arm of this study will assess the utility of short-term oral anticoagulation with warfarin comp...

see more →

News  491 results

American Heart Association (AHA) Scientific Sessions 2021 Highlights: Surgery and Drugs
https://www.medscape.com/viewarticle/963825_slide

Dec 16th, 2021 - Related News and Commentary Early SAVR Tops Watchful Waiting in Severe, Asymptomatic Aortic Stenosis: AVATAR Despite Positive Trials, Early Surgery in Asymptomatic AS Should Wait Concomitant Tricuspid-Mitral Surgery Beneficial but With a Tradeoff ...

Surgical Consult From AHA: Act Earlier in Aortic Stenosis and Tricuspid Regurgitation?
https://www.medscape.com/viewarticle/962980

Nov 19th, 2021 - This transcript has been edited for clarity. Michelle O'Donoghue, MD: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape from day 1 of the AHA Scientific Sessions, which this year are being held virtually. Live on the scene I have Dr Pat O...

Nov 19, 2021 This Week in Cardiology Podcast
https://www.medscape.com/viewarticle/963288

Nov 19th, 2021 - Please note that the text below is not a full transcript and has not been copyedited. For more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast on Apple Podcasts, Spotify, or your preferred podcast provider...

Despite Positive Trials, Early Surgery in Asymptomatic AS Should Wait
https://www.medscape.com/viewarticle/962926

Nov 15th, 2021 - Now there are not one but two 'positive' randomized controlled trials on early surgical aortic valve replacement in patients with severe but asymptomatic aortic stenosis (AS). You may think that is enough to change the practice of watchful waiting...

Early SAVR Tops Watchful Waiting in Severe, Asymptomatic Aortic Stenosis: AVATAR
https://www.medscape.com/viewarticle/962904

Nov 13th, 2021 - Better to intervene early with a new valve in patients with severe aortic stenosis (AS) who are asymptomatic, even during exercise, than to wait for the disease to progress and symptoms to emerge before operating, suggests a small, randomized tria...

see more →

Patient Education  4 results see all →